The global omega 3 supplements market size is expected to reach USD 10.80 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.6% from 2020 to 2028. The demand for omega-3 supplements is projected to be driven by the growing adoption of the product to fulfill the daily nutritional requirements and maintain optimum health of organs by the geriatric population in developed economies, such as the U.S., Canada, the U.K., and France.
Furthermore, the outbreak of COVID-19 from the beginning of 2020 led to increased consumer awareness regarding the significance of immunity and immunity-boosting products, which is expected to fuel the demand for various omega fatty acids products. Increasing incorporation of products in gummies form with novel flavor is expected to increase product penetration among children in the coming years.
Docosahexaenoic acid (DHA) is an omega-3 fatty acid comprising over 93.0% of omega-3 fats in the retina and 97.0% in the human brain. Rising demand for DHA supplements for pregnant ladies owing to lack of adequate DHA in the diet is expected to drive the market. Additionally, increasing demand for omega-3 DHA-rich supplements from non-lactating mothers is expected to propel the product demand over the forecast period.
Rising chronic diseases such as strokes, arthritis, coronary heart diseases, and cancer are expected to propel the demand for omega 3 supplements over the upcoming years. According to the World Health Organization (WHO), over 14 million people between the ages of 30 and 70 die every year due to distinguished chronic diseases. Rising government support to provide consumers with low-cost preventive drugs is projected to propel the demand for omega 3 supplements over the forecast period.
Request a free sample copy or view report summary: Omega 3 Supplements Market Report
In terms of source, the krill oil-based omega 3 supplements are projected to expand at the fastest CAGR of 11.1% over the projected period on account of the growing demand for eicosapentaenoic acid (EPA) and DHA-based supplements among consumers globally
On the basis of functionality, the cardiovascular health segment accounted for over 37.0% share of the overall revenue in 2019. The growing prevalence of cardiovascular diseases as a result of the slow and inactive lifestyle, especially in the age group of 30 to 40 years, and fluctuating dietary patterns are anticipated to spur the segment growth over the next few years
The market in China is expected to witness significant growth over the upcoming years owing to the propelling spending capacity of consumers. Easy online availability of these supplements in the country has also strengthened its demand in the country
Strong mass channels of distribution, online sales, and a growing number of standalone mass facing brands by several companies, including Optimum Nutrition; Herbalife International of America, Inc.; Now Foods., and Amway are the key factors expected to fuel the demand for fish oil-based omega 3 supplements over the upcoming years
In September 2020, Aker BioMarine launched a new support vessel at Yantai yard, China. The new vessel's launching has assured the stakeholders that the lockdown due to the COVID-19 pandemic has not affected the company
Grand View Research has segmented the global omega 3 supplements market on the basis of source, form, functionality, end-user, distribution channel, and region:
Omega 3 Supplements Source Outlook (Revenue, USD Million, 2017 - 2028)
Fish Oil
Krill Oil
Algae Oil
Others
Omega 3 Supplements Form Outlook (Revenue, USD Million, 2017 - 2028)
Tablets
Capsules
Soft Gels
Others
Omega 3 Supplements Functionality Outlook (Revenue, USD Million, 2017 - 2028)
Cardiovascular Health
Brain, Nervous System & Mental Health
Eye Diseases
Diabetes
Others
Omega 3 Supplements End-user Outlook (Revenue, USD Million, 2017 - 2028)
Adults
Geriatric
Pregnant Women
Children
Infants
Omega 3 Supplements Distribution Channel Outlook (Revenue, USD Million, 2017 - 2028)
OTC
Supermarkets/ Hypermarkets/Food Stores
Drug Stores & Pharmacies
Online Retailers
Others
Prescribed
Omega 3 Supplements Regional Outlook (Revenue, USD Million, 2017 - 2028)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
The Netherlands
Italy
Spain
Norway
Asia Pacific
China
India
Japan
Australia
New Zealand
Central & South America
Brazil
Argentina
Middle East & Africa
UAE
List of Key Players of Omega 3 Supplements Market
Nordic Naturals, Inc.
NutriGold Inc.
Reckitt Benckiser Group plc
Pharma Nord B.V
i-Health, Inc.
Aker BioMarine AS
Luhua Biomarine (Shandong) Co., Ltd.
Pharmavite LLC
KD Pharma Group
NOW Foods
GlaxoSmithKline plc
Natrol LLC
Carlson Laboratories
OmegaBrite
Optimum Nutrition, Inc.
VAYA Pharma
Vital Choice Wild Seafood & Organics, SPC
Bionova
The Nature’s Bounty Co.
Arkopharma
"The quality of research they have done for us has been excellent..."